9 months ago
PFE
AnalystsAlexandria HammondAlexandria Hammond's Stock Forecasts
AnalystsAlexandria Hammond
Sectors:
Industries:
Analyst Ranking
Bottom 27%
#3676 out of 4989 analysts
Average Return
-0.5%
Win Rate
45%5 out of 11
Risk vs Reward
Poor
Good
Alexandria Hammond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gilead Sciences IncGILD | +34.31% | $88.40 | $118.73 | 2024‑11‑14 - 2025‑08‑20 | Buy |
Moderna IncMRNA | +27.03% | $36.85 | $26.89 | 2024‑11‑14 - 2025‑08‑20 | Sell |
Abbvie IncABBV | +26.77% | $164.99 | $209.15 | 2024‑11‑14 - 2025‑08‑20 | Buy |
Johnson & JohnsonJNJ | +16.13% | $154.00 | $178.84 | 2024‑11‑14 - 2025‑08‑20 | Buy |
Akero Therapeutics IncAKRO | +4.24% | $46.00 | $47.95 | 2025‑05‑26 - 2025‑08‑20 | Strong Buy |
Alexandria Hammond Analyst Color
Get additional color on Alexandria Hammond's coverage of popular stocks
9 months ago
LLY
Alexandria Hammond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Akero Therapeutics IncAKRO | 4 | Strong Buy | $64.00 | +33.47% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $1,150.00 | +94.58% | Initiates Coverage On | 9 months ago |
Pfizer IncPFE | 1 | Sell | $25.00 | -1.50% | Initiates Coverage On | 9 months ago |
Moderna IncMRNA | 1 | Sell | $40.00 | +48.75% | Initiates Coverage On | 9 months ago |
Eli Lilly & CoLLY | 1 | Buy | $1,000.00 | +41.76% | Initiates Coverage On | 9 months ago |
Johnson & JohnsonJNJ | 1 | Buy | $190.00 | +6.24% | Initiates Coverage On | 9 months ago |
Gilead Sciences IncGILD | 1 | Buy | $110.00 | -7.35% | Initiates Coverage On | 9 months ago |
Abbvie IncABBV | 1 | Buy | $205.00 | -1.98% | Initiates Coverage On | 9 months ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Sell | $150.00 | N/A | Initiates Coverage On | a year ago |
89bio IncETNB | 1 | Strong Buy | $30.00 | N/A | Assumes | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.